Expanding Access and Lowering Costs We believe every research institution deserves access to high-quality, verified materials
This supports the hypothesis that ciliopathies, such as BBS, involve intrinsic defects in leptin and insulin pathways that are exacerbated, rather than solely caused, by obesity
New fat-burning diabetes pill protects muscle and appetite Date: December 7, 2025 Source: Karolinska Institutet Summary: Researchers have developed a new oral drug that boosts metabolic activity in muscle rather than altering appetite like GLP-1 drugs
You know, its interesting
"Our rigorous, customer-first approach strips away the friction of traditional healthcare, putting the power of health ownership back where it belongs: with the consumer. Wegovy is the only FDA-approved GLP-1 obesity pill Novo is the only company to gain FDA approval for a GLP-1 weight loss pill
What is the MOQ (minimum order quantity)